Showing papers in "Journal of Substance Abuse Treatment in 2015"
••
TL;DR: It is concluded that brief alcohol interventions yield beneficial effects on alcohol-related outcomes for adolescents and young adults that are modest but potentially worthwhile given their brevity and low cost.
359 citations
••
TL;DR: Results suggest that SMS text messaging may be a promising way to improve smoking cessation outcomes, given the relatively wide reach and low cost of text message interventions.
145 citations
••
TL;DR: While substance abuse treatment centers have increased treatment volume to address the increase in prescription opioid dependence among pregnant women, targeting certain risk groups and increasing utilization of medication assisted therapy should be emphasized.
136 citations
••
TL;DR: Prevalence of nonmedical prescription opioid (PO) use has increased markedly in the U.S. and young adult nonmedical PO users are engaging in unprotected sex with casual partners, exchange sex and group sex, and that PO misuse increases the risk of sexual violence.
116 citations
••
TL;DR: Relaxed BMT program requirements and frequent counsel on the high probability of relapse if BMT is discontinued may improve retention in treatment and prevent the relapse to illicit opioid use that is likely to follow BMT discontinuation.
113 citations
••
TL;DR: Figures show that Medicaid funding, opioid overdose deaths, and specific state guidance for office-based buprenorphine use were associated with more bup Renorphine-waivered physicians, while encouraging methadone programs to promote bupreliminary use had no impact.
104 citations
••
TL;DR: In general, the DUDIT yields satisfactory measures of reliability and validity for use as a clinical or research tool and results on the factor structure, however, are somewhat equivocal.
94 citations
••
TL;DR: An overview of the current status of the research literature in this area is provided, including a sampling of the latest research on the epidemiology, clinical correlates, treatment, and public policy considerations of prescription drug abuse.
92 citations
••
TL;DR: The effectiveness of OAT that has been demonstrated in clinical trials persists at the population level in a less controlled setting and that OAT is associated with lower total healthcare expenditures compared to other forms of behavioral treatment for patients with opioid addiction is suggested.
92 citations
••
TL;DR: It is indicated that exercise may have beneficial effects on certain domains of physical functioning including VO2max, basal heart rate, physical activity level and strength and several mechanisms of action are conceivable, especially as to alcohol-related outcomes and additionally seem to be promising.
87 citations
••
TL;DR: The ED was the most cost-effective setting if decision makers were willing to pay more than $1500 per QALY gained and alcohol SBIRT generates costs savings and improves health in both ED and outpatient settings.
••
TL;DR: The Affordable Care Act and the Mental Health Parity and Addiction Equity Act (Parity Act) signal remarkable changes in how SUDs are to be conceptualized and managed as well as how they are evaluated for effectiveness and value.
••
TL;DR: It is suggested that training does not increase correspondence between self-report and objective assessment, so community treatment programs should not rely on clinician self- report to assess the need for ongoing training and supervision and it may be necessary to train clinicians to accurately assess their own skill.
••
TL;DR: Analysis of data from the 2008-2012 National Survey on Drug Use and Health finds that increased service utilization is associated with perceiving a need for substance abuse treatment, implying that outreach initiatives to raise awareness about SUD and the effective role of substance use treatment are needed to enhance the impact of the structural changes to the substance Abuse treatment system resulting from the ACA.
••
TL;DR: Results support the role of a structured exercise program as an effective intervention for improving symptoms of depression and anxiety associated with MA abstinence.
••
TL;DR: A population-based, nested case-control study linking healthcare and coroner's records in Ontario, Canada, from January 31, 1994 to December 31, 2010, found psychotropic drug use is associated with opioid-related death in patients receiving methadone, and mindfulness of these factors may reduce the risk of death among Methadone recipients.
••
TL;DR: A significant reduction in levels of distress, depression and craving and improved HRQL occurred for both arms, whereas self-efficacy and social support remained unchanged in both groups.
••
Rhode Island Hospital1, Veterans Health Administration2, University of Kentucky3, National Institute on Drug Abuse4, Temple University5, University of Connecticut6, Texas Christian University7, University of Puerto Rico8, University of California, Los Angeles9, Arizona State University10, West Chester University of Pennsylvania11
TL;DR: Knowledge, perceptions and information training plus interorganizational strategic planning intervention is an effective means to change attitudes and intent to refer clients for medication assisted treatment in community corrections settings, especially among corrections staff.
••
TL;DR: In this paper, the authors examined patient experiences and outcomes with 12-step recovery group attendance during buprenorphine maintenance treatment (BMT), two approaches with traditionally divergent philosophies regarding opioid medications for treatment of opioid use disorder.
••
TL;DR: Gender-specific predictors of MMT retention and opioid abstinence are indicated and future studies on MMT outcomes should examine each gender separately, and consider unique pathways by which females and males adhere to, and benefit from MMT.
••
TL;DR: Findings support admission screening with the ASI/cortisol for drop out, and stress/drug-use indices for engagement that together may enable clinically-relevant early recognition and interventions for prevention of stress-induced relapse in opioid-dependent populations.
••
TL;DR: The first nationwide survey of CRP-enrolled students highlights the need for treatment, recovery support programs and college health services to provide integrated support for mental health and behavioral addictions to SUD--affected young people.
••
TL;DR: A systematic review of the literature using indexed terms and key words to capture the concepts of smoking, pregnancy, and opioid substitution found that only three studies met search criteria and contingency management, an incentive based treatment, was the most promising intervention.
••
TL;DR: The propensity to more steeply discount delayed rewards in drug users has the potential to become a clinically relevant behavioral marker, alerting clinicians that these clients may exhibit lower treatment readiness and are more likely to drop out of treatment prematurely.
••
TL;DR: Findings suggest that physicians should assess for use/misuse of atypical antipsychotics among patients with addiction, and ASI composite scores were higher.
••
TL;DR: It is suggested that completing the entire course of treatment (6 injections) may reduce opioid use and, to a lesser degree, re-arrest and re-incarceration and may be a feasible option in the prison setting in view of the lack of potential for diversion.
••
TL;DR: Methadone treatment enrollment was associated with clinically significant weight gain, particularly among female patients, which highlights the importance of efforts to help patients mitigate weight gain during treatment, particularly considering the significant health and economic consequences of obesity for individuals and society more generally.
••
TL;DR: E-cigs should be a part of smoking cessation discussions with this vulnerable, difficult-to-treat population of opioid dependent smokers, and how to optimize their utility as a cessation tool remains undefined.
••
TL;DR: Examination of 18-month post-randomization outcomes of participants in the Prescription Opioid Addiction Treatment Study found that greater pain severity at baseline was associated with opioid dependence at 18 months, and although opioid use outcomes during the treatment trial were poor immediately following a buprenorphine-naloxone taper compared to those during 12 weeks of bupreliminary stabilization, opioids use outcomes at 18- month follow-up showed substantial improvement over baseline.
••
TL;DR: Investigation of illicit buprenorphine use and barriers to BMT among syringe exchange participants found users were interested in BMT but did not know where to go for treatment, and addressing barriers toBMT could reduce illicit buPrenorphines use.